Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis.

Mycoses
B PosteraroSEIFEM group

Abstract

Candidaemia is an important infectious complication for haematological malignancy patients. Antifungal prophylaxis reduces the incidence of candidaemia but may be associated with breakthrough candidaemia. To analyse the Candida species' distribution and relative antifungal susceptibility profiles of candidaemia episodes in relation to the use of antifungal prophylaxis among Italian SEIFEM haematology centres. This multicentre retrospective observational SEIFEM study included 133 single-species candidaemia episodes of haematological malignancy patients for whom antifungal susceptibility testing results of blood Candida isolates were available between 2011 and 2015. Each participating centre provided both clinical and microbiological data. Non-Candida albicans Candida (NCAC) species were the mostly isolated species (89, 66.9%), which accounted for C parapsilosis (35, 26.3%), C glabrata (16, 12.0%), C krusei (14, 10.5%), C tropicalis (13, 9.8%) and uncommon species (11, 8.3%). C albicans caused the remaining 44 (33.1%) episodes. Excluding 2 C albicans isolates, 23 of 25 fluconazole-resistant isolates were NCAC species (14 C krusei, 6 C glabrata, 2 C parapsilosis and 1 C tropicalis). Fifty-six (42.1%) of 133 patients developed brea...Continue Reading

References

Jan 28, 2006·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Kenneth V I RolstonDah H Ho
Oct 6, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L PaganoF Aversa
Jan 31, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Michele I Morris
Mar 12, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dimitrios P KontoyiannisPeter G Pappas
Jan 4, 2012·The American Journal of Medicine·Michael A Pfaller
Dec 13, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E BouzaUNKNOWN GEIDI and the COMIC study groups
Jul 31, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M N GamaletsouN V Sipsas
Dec 10, 2013·Hematology·Thomas J Walsh, Maria N Gamaletsou
Jan 1, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M C Arendrup
May 16, 2014·Journal of Clinical Microbiology·Ki-Ho ParkSung-Han Kim
May 28, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N LerolleM Lafaurie
Jul 8, 2015·Eukaryotic Cell·Shelby J Priest, Michael C Lorenz
Oct 9, 2015·The New England Journal of Medicine·Bart Jan Kullberg, Maiken C Arendrup
Dec 18, 2015·Future Microbiology·Sue Lyon
Jun 19, 2016·The Journal of Antimicrobial Chemotherapy·Lena M BiehlMaria J G T Vehreschild
Mar 23, 2017·Intensive Care Medicine·Olivier LortholaryUNKNOWN French Mycoses Study Group
Jul 22, 2017·Haematologica·Livio PaganoUNKNOWN SEIFEM group (Sorveglianza Epidemiologica Infezioni Fungine in Ematologia)
Sep 16, 2017·The Journal of Infectious Diseases·Luis Ostrosky-Zeichner, David Andes
Jan 6, 2018·The Journal of Antimicrobial Chemotherapy·Matteo BassettiOliver A Cornely
Aug 8, 2018·The Journal of Antimicrobial Chemotherapy·Johan A MaertensUNKNOWN European Conference on Infections in Leukaemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplant
Feb 9, 2019·European Journal of Clinical Investigation·Marianna CriscuoloUNKNOWN SEIFEM Group (Sorveglianza Epidemiologica Infezioni nelle Emopatie)
Mar 22, 2019·Open Forum Infectious Diseases·Michael A PfallerRonald N Jones
Apr 10, 2019·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K E Pristov, M A Ghannoum

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.